View Financial HealthBlackhawk Growth 배당 및 자사주 매입배당 기준 점검 0/6Blackhawk Growth 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공고 • Jun 05+ 1 more updateBlackhawk Growth Corp. Announces CEO Changes, Effective May 25, 2026Blackhawk Growth Corp. announced that, effective May 25, 2026, Justin Hanka has also resigned as Chief Executive Officer of the Company. The Board and management team would like to express their sincere appreciation to the outgoing directors and officer for their contributions and service to the Company. The Company is pleased to announced, effective May 25, 2026, the appointment of Mr. Jae-In (Jay) Sun as Chief Executive Officer of the Company. Mr. Sun is a seasoned business architect, investment structuring expert, and technology executive with over 30 years of experience across corporate finance, alternative investments, and emerging technology sectors. Mr. Sun has extensive expertise in Mezzanine financing, Private Investment in Public Equity (PIPE) transactions, cross-border Special Purpose Companies (SPCs), Joint Ventures, and strategic M&A advisory for both public and private companies. Over the past decade, he has focused on high-growth technology sectors including IT infrastructure, blockchain, cryptocurrency, AI and quantum computing ecosystems. He currently serves as Head of International Business at PNBS Co. Ltd., where he leads global capital market strategy and international business development initiatives supporting the commercialization of advanced AI and quantum infrastructure technologies.공고 • Nov 22Blackhawk Growth Corp. Announces Board ChangesBlackhawk Growth Corp. announced Appointment of Kyung-Hoon Park as New Director, effective 21 November 2025. Kyung-Hoon (Charlie) Park is an entrepreneur with over ten years of experience operating multiple companies in technology and platform-driven industries. He has served as both CEO and CTO, leading service architecture design, technical development, digital transformation, and operational optimization. His expertise spans startup discovery, business model validation, scalable growth strategies, and strategic partnerships including fundraising support. With successful exit experience from a technology-driven company, he brings strong capabilities in value creation and tech-focused M&A execution. He contributes to the growth and global expansion of technology-oriented organizations through execution-driven leadership and practical problem-solving skills. Anthony Haberfield has resigned as director.공고 • Mar 25Blackhawk Growth Corp. announced that it expects to receive CAD 0.504 million in fundingBlackhawk Growth Corp. announced a non-brokered private placement that it will issue up to 28,000,000 shares at an issue price of CAD 0.018 per share for the gross proceeds of up to CAD 504,000 on March 24, 2025. All securities issued under the Offering are subject to a four-month and one day statutory hold period. Finder's fees may be payable to qualified individuals pursuant to which the Finder may receive a finder fee equal to up to 8% of the gross proceeds received by the Company from purchasers under the Offering who were introduced to the Company. The Company is also pleased to announce that Shape Capital has agreed to convert CAD 500,000 of the outstanding loan at CAD 0.05 by issuing 10,000,000 shares. The conversion reduces the debt by 22% and further strengthen Blackhawk’s balance sheet.공고 • Apr 17Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI TechnologyBlackhawk Growth Corp. provided an update on Asthmatic AI. The company reported that Asthmatic AI, a company has completed 50 participants in human clinical trials and is now working on the next 250 participants as it develops its Asthma attack prediction technology for use in the clinical management of Asthma. Uniquely, Asthmatic AI uses wearable devices and a mobile application over smartphone to collect data, assess the risk of an asthma attack occurring and then intervene before it occurs. The AI models cross reference an individual's biophysical information such as heart rate, respiratory rate, heart rate variability, blood pressure, cough and wheeze rates with public health data, pollen and location data to interpret an individual's risk of an asthma attack. With over 1,000 asthma deaths reported daily according to the World Health Organization and the burden on social, employment, education and family, Asthmatic AI proposes a novel solution for the management of this serious health condition. Hardenbrook Group works with world class research-intensive organizations to identify valuable intellectual property to invest and commercialize. This provides Blackhawk with the ability to incubate and either M&A or spin out these new innovative companies as a new listing on stock exchanges globally. Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI with a significant pipeline of health-tech AI related projects for launch in the near horizon. Life AI Corp. will be the holding company for all health tech AI companies and is also preparing to be spun out and publicly listed.공고 • Apr 03Blackhawk Growth Corp., Annual General Meeting, May 17, 2024Blackhawk Growth Corp., Annual General Meeting, May 17, 2024.공고 • May 31Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million.Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million on May 29, 2023. Pursuant to the terms of a share purchase agreement, dated May 29, 2023, the Company to acquire all of the outstanding share capital of Hardenbrook Group Pty Ltd to issue 70,000,000 common shares to the existing shareholders of Hardenbrook at a deemed price of AUD 0.05 per share and 15,000,000 Warrants with an exercise price of AUD 0.10. No finders’ fees or commissions were paid in connection with closing of the acquisition. The acquisition of Hardenbrook is subject to shareholder approval. Further updates will be provided to shareholders. As a result the issued share capital will increase from 77,995,593 Shares to 147,995,593 Shares. Shareholder approval and CSE approval is required and a valuation report will be obtained.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 BLRZ.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: BLRZ.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Blackhawk Growth 배당 수익률 vs 시장BLRZ.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (BLRZ.F)0%시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Capital Markets)2.0%분석가 예측 (BLRZ.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 BLRZ.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 BLRZ.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: BLRZ.F US 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: BLRZ.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/01/26 14:03종가2025/10/29 00:00수익2025/09/30연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Blackhawk Growth Corp.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공고 • Jun 05+ 1 more updateBlackhawk Growth Corp. Announces CEO Changes, Effective May 25, 2026Blackhawk Growth Corp. announced that, effective May 25, 2026, Justin Hanka has also resigned as Chief Executive Officer of the Company. The Board and management team would like to express their sincere appreciation to the outgoing directors and officer for their contributions and service to the Company. The Company is pleased to announced, effective May 25, 2026, the appointment of Mr. Jae-In (Jay) Sun as Chief Executive Officer of the Company. Mr. Sun is a seasoned business architect, investment structuring expert, and technology executive with over 30 years of experience across corporate finance, alternative investments, and emerging technology sectors. Mr. Sun has extensive expertise in Mezzanine financing, Private Investment in Public Equity (PIPE) transactions, cross-border Special Purpose Companies (SPCs), Joint Ventures, and strategic M&A advisory for both public and private companies. Over the past decade, he has focused on high-growth technology sectors including IT infrastructure, blockchain, cryptocurrency, AI and quantum computing ecosystems. He currently serves as Head of International Business at PNBS Co. Ltd., where he leads global capital market strategy and international business development initiatives supporting the commercialization of advanced AI and quantum infrastructure technologies.
공고 • Nov 22Blackhawk Growth Corp. Announces Board ChangesBlackhawk Growth Corp. announced Appointment of Kyung-Hoon Park as New Director, effective 21 November 2025. Kyung-Hoon (Charlie) Park is an entrepreneur with over ten years of experience operating multiple companies in technology and platform-driven industries. He has served as both CEO and CTO, leading service architecture design, technical development, digital transformation, and operational optimization. His expertise spans startup discovery, business model validation, scalable growth strategies, and strategic partnerships including fundraising support. With successful exit experience from a technology-driven company, he brings strong capabilities in value creation and tech-focused M&A execution. He contributes to the growth and global expansion of technology-oriented organizations through execution-driven leadership and practical problem-solving skills. Anthony Haberfield has resigned as director.
공고 • Mar 25Blackhawk Growth Corp. announced that it expects to receive CAD 0.504 million in fundingBlackhawk Growth Corp. announced a non-brokered private placement that it will issue up to 28,000,000 shares at an issue price of CAD 0.018 per share for the gross proceeds of up to CAD 504,000 on March 24, 2025. All securities issued under the Offering are subject to a four-month and one day statutory hold period. Finder's fees may be payable to qualified individuals pursuant to which the Finder may receive a finder fee equal to up to 8% of the gross proceeds received by the Company from purchasers under the Offering who were introduced to the Company. The Company is also pleased to announce that Shape Capital has agreed to convert CAD 500,000 of the outstanding loan at CAD 0.05 by issuing 10,000,000 shares. The conversion reduces the debt by 22% and further strengthen Blackhawk’s balance sheet.
공고 • Apr 17Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI TechnologyBlackhawk Growth Corp. provided an update on Asthmatic AI. The company reported that Asthmatic AI, a company has completed 50 participants in human clinical trials and is now working on the next 250 participants as it develops its Asthma attack prediction technology for use in the clinical management of Asthma. Uniquely, Asthmatic AI uses wearable devices and a mobile application over smartphone to collect data, assess the risk of an asthma attack occurring and then intervene before it occurs. The AI models cross reference an individual's biophysical information such as heart rate, respiratory rate, heart rate variability, blood pressure, cough and wheeze rates with public health data, pollen and location data to interpret an individual's risk of an asthma attack. With over 1,000 asthma deaths reported daily according to the World Health Organization and the burden on social, employment, education and family, Asthmatic AI proposes a novel solution for the management of this serious health condition. Hardenbrook Group works with world class research-intensive organizations to identify valuable intellectual property to invest and commercialize. This provides Blackhawk with the ability to incubate and either M&A or spin out these new innovative companies as a new listing on stock exchanges globally. Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI with a significant pipeline of health-tech AI related projects for launch in the near horizon. Life AI Corp. will be the holding company for all health tech AI companies and is also preparing to be spun out and publicly listed.
공고 • Apr 03Blackhawk Growth Corp., Annual General Meeting, May 17, 2024Blackhawk Growth Corp., Annual General Meeting, May 17, 2024.
공고 • May 31Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million.Blackhawk Growth Corp. (CNSX:BLR) entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million on May 29, 2023. Pursuant to the terms of a share purchase agreement, dated May 29, 2023, the Company to acquire all of the outstanding share capital of Hardenbrook Group Pty Ltd to issue 70,000,000 common shares to the existing shareholders of Hardenbrook at a deemed price of AUD 0.05 per share and 15,000,000 Warrants with an exercise price of AUD 0.10. No finders’ fees or commissions were paid in connection with closing of the acquisition. The acquisition of Hardenbrook is subject to shareholder approval. Further updates will be provided to shareholders. As a result the issued share capital will increase from 77,995,593 Shares to 147,995,593 Shares. Shareholder approval and CSE approval is required and a valuation report will be obtained.